REGN (STOCKS)
Regeneron Pharmaceuticals Inc
$613.476600
+1.336600 (+0.22%)
Prev close: $612.140000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Leonard S. Schleifer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $64,473.98M
- Employees
- 15,207
- P/E (TTM)
- 14.91
- P/B (TTM)
- 2.05
- Dividend Yield
- 59.46%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $14.92B |
| Benefits Costs and Expenses | $9.76B |
| Costs And Expenses | $11.29B |
| Nonoperating Income/Loss | $1.53B |
| Operating Expenses | $11.29B |
| Selling, General, and Administrative Expenses | $2.71B |
| Research and Development | $6.07B |
| Other Operating Expenses | $2.51B |
| Operating Income/Loss | $3.63B |
| Income/Loss From Continuing Operations After Tax | $4.42B |
| Income/Loss From Continuing Operations Before Tax | $5.16B |
| Income Tax Expense/Benefit | $733.50M |
| Net Income/Loss | $4.42B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $4.42B |
| Net Income/Loss Available To Common Stockholders, Basic | $4.42B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $42.56 |
| Diluted Earnings Per Share | $41.05 |
| Basic Average Shares | 312,200,000 |
| Diluted Average Shares | 323,200,000 |
| Assets | $40.87B |
| Current Assets | $18.21B |
| Inventory | $3.10B |
| Other Current Assets | $15.11B |
| Noncurrent Assets | $22.66B |
| Intangible Assets | $1.29B |
| Other Non-current Assets | $21.37B |
| Liabilities | $9.45B |
| Current Liabilities | $5.11B |
| Accounts Payable | $1.03B |
| Other Current Liabilities | $4.08B |
| Noncurrent Liabilities | $4.34B |
| Equity | $31.42B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $31.42B |
| Liabilities And Equity | $40.87B |
| Net Cash Flow From Operating Activities | $5.01B |
| Net Cash Flow From Operating Activities, Continuing | $5.01B |
| Net Cash Flow From Investing Activities | -$1.71B |
| Net Cash Flow From Investing Activities, Continuing | -$1.71B |
| Net Cash Flow From Financing Activities | -$3.43B |
| Net Cash Flow From Financing Activities, Continuing | -$3.43B |
| Exchange Gains/Losses | -$1.20M |
| Net Cash Flow | -$122.40M |
| Net Cash Flow, Continuing | -$121.20M |
| Comprehensive Income/Loss | $4.38B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $4.41B |
| Other Comprehensive Income/Loss | $2.99B |
| Other Comprehensive Income/Loss Attributable To Parent | -$17.20M |